Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 19 February 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Survival with liver transplant in primary biliary cirrhosis is high

The latest Clinical Transplantation shows excellent survival rates with 15 years follow-up after liver transplantation in primary biliary cirrhosis, and that recipient's age, and tacrolimus immunosuppression are risk factors recurrence.

News image

fiogf49gjkf04

Orthotopic liver transplantation is the only effective curative therapy for end-stage primary biliary cirrhosis.

Survival after orthotopic liver transplantation is excellent.

However, recent data have shown a recurrence rate of primary biliary cirrhosis of up to 32% after transplantation.

Dr Dietmar Jacoba and colleagues from Germany investigated the course after disease recurrence.

The researchers particularly assessed liver function and survival with long-term follow-up.

The team performed 1553 liver transplantations in 1415 patients at the Charité, Virchow Clinic, between 1989 and 2003.

Protocol liver biopsies were taken after 1, 3, 5, 7, 10 and 13 years.

The team reported that 7% of patients suffered from histologically proven primary biliary cirrhosis.

Patient survival after 15 years was 82%
Clinical Transplantation

Primary immunosuppression consisted of cyclosporine or tacrolimus.

Immediately after orthotopic liver transplantation, all patients received ursodeoxycholic acid.

The research team withdrew corticosteroids 3 to 6 months after orthotopic liver transplantation.

The team noted that the median age of the 85 women and 15 men was 55 years.

The median follow-up after liver transplantation was 118 months, and 30 months after recurrence 30 months.

The researchers found that actuarial patient survival after 5, 10 and 15 years was 87%, 84% and 82% respectively.

The team reported that 10% of patients died after a median survival time of 32 months.

Of the patients that died, 2 developed organ dysfunction owing to recurrence of primary biliary cirrhosis.

Histological recurrence was found in 14% of patients after a median time of 61 months.

The team observed that patients with tacrolimus immunosuppression developed primary biliary cirrhosis recurrence more often, and also earlier.

The research team identified 57 patients that developed an acute rejection, and 2 patients with a chronic rejection episode.

Liver function did not alter within the first 5 years after histologically proven primary biliary cirrhosis recurrence.

Dr Jacoba's team concluded, “Multivariate analysis of the investigated patients showed that the recipient's age and tacrolimus immunosuppression were significant risk factors for primary biliary cirrhosis recurrence.”

“Long-term follow-up of up to 15 years after liver transplantation, owing to primary biliary cirrhosis, in addition to maintenance of liver function, shows excellent organ and patient survival rates.”

“Although protocol liver biopsies revealed histological recurrence in 14% patients, only 2 patients developed graft dysfunction.”

“Tacrolimus-treated patients showed more frequently and also earlier histologically proven primary biliary cirrhosis recurrence.”

“However, in our population we could not observe an impact on graft dysfunction and patient's survival.”

Clin Transplant 2006:20(2):211
09 May 2006

Go to top of page Email this page Email this page to a colleague

 19 February 2018 
The effectiveness of screening colonoscopy in the right colon was not significantly different from that in the left colon/rectum
 19 February 2018 
No significant differences, among racial or ethnic groups, found in patients with significant fibrosis
 19 February 2018 
Hydrogen production greater in patients on a fructan-containing diet, than those following a maltodextrin-containing diet

 16 February 2018 
Undetected celiac in the elderly
 16 February 2018 
Inflammatory bowel diseases are global diseases
 16 February 2018 
Fructans induce non-celiac gluten sensitivity
 15 February 2018 
Oral direct-acting antiviral treatment for Hep C virus genotype 1
 15 February 2018 
NSAIDS and GI damage
 15 February 2018 
Primary vs secondary surgery for the presence of lymph node metastasis
 14 February 2018 
Management of hemorrhoids in the USA
 14 February 2018 
Predicting adenoma detection rate
 14 February 2018 
Normal bowel frequency characterization in the USA 
 13 February 2018 
Prebiotics improve endothelial dysfunction
 13 February 2018 
Personalising treatment options for IBS
 13 February 2018 
Diagnostic criteria for a Rome IV functional gastrointestinal disorders
 12 February 2018 
Visceral hypersensitivity and functional GI disorders
 12 February 2018 
Depression and aggressive IBD
 12 February 2018 
Variability in interpretation of endoscopic findings impacts patient management
 09 February 2018 
Treatment of choice for anastomotic stricture in IBD
 09 February 2018 
PRO measurement information system 
 09 February 2018 
Overall disease severity indices for IBD
 08 February 2018 
Prediction of endoscopically active disease

 08 February 2018 
Steroid-refractory acute severe ulcerative colitis
 08 February 2018 
Decision aid used by IBD patients
 07 February 2018 
Ursodeoxycholic acid combined with bezafibrate for itching
 07 February 2018 
Change in microbiome in gastritis vs gastric carcinoma
 07 February 2018 
Colorectal cancer and primary sclerosing cholangitis-IBD
 06 February 2018 
Risk of death after liver transplantation
 06 February 2018 
Crohn’s disease vs refractory pouchitis
 06 February 2018 
Support for functional dyspepsia symptom diary
 05 February 2018 
Helicobacter spp influence on GI tract 
 05 February 2018 
No link found between severe reflux and all-cause mortality 
 05 February 2018 
Psychological distress in PPI non-responders
 02 February 2018 
Assessing psychosexual impact of IBD
 02 February 2018 
Decrease in overall mortality with cholera vaccination
 02 February 2018 
Diagnostic performance of fecal immunochemical tests
 01 February 2018 
Screening frequency with family histories of colorectal cancer
 01 February 2018 
IBD and sport participation
 01 February 2018 
Life with a stoma 
 31 January 2018 
Aprepitant and gastroparesis 
 31 January 2018 
Anesthesia risk in colonoscopy
 31 January 2018 
GED-0301 for Crohn's Disease
 30 January 2018 
Intestinal dysbiosis and allergic diseases in infants
 30 January 2018 
Fructans and IBS symptoms in children
 29 January 2018 
Dosing calculator for therapy optimization in IBD
 29 January 2018 
Glecaprevir–pibrentasvir for in HCV
 29 January 2018 
Food allergen injections in eosinophilic esophagitis
 29 January 2018 
Reliability of the IBD index
 26 January 2018 
Tofacitinib vs biological therapies for ulcerative colitis
 26 January 2018 
Optimizing selection of biologics in IBD
 26 January 2018 
Nutritional risk and laparoscopic-assisted gastrectomy outcomes
 25 January 2018 
Patient-reported outcome measure for functional dyspepsia
 25 January 2018 
Predicting intra-abdominal infections after colorectal surgery
 25 January 2018 
Predictors of gastric cancer risk
 24 January 2018 
Risk factors underlying previously undiagnosed cirrhosis
 24 January 2018 
Ethnicity influences phenotype in IBD
 24 January 2018 
Bariatric surgery vs medical obesity treatment
 23 January 2018 
Atrophic gastritis after H. pylori eradication
 23 January 2018 
Ectopic pregnancy in women with IBD
 23 January 2018 
Celiac disease in IBS in the USA

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us